A knee bone age-based predictive nomogram for the poor response to growth hormone therapy in children with idiopathic short stature during mid-to-late puberty
- PMID: 40864382
- DOI: 10.1007/s12020-025-04398-2
A knee bone age-based predictive nomogram for the poor response to growth hormone therapy in children with idiopathic short stature during mid-to-late puberty
Keywords: Bone age; Growth hormone therapy; Idiopathic short stature; Magnetic resonance imaging; Puberty.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Statements and Declarations: This study was funded by the National Key Research and Development Program, with data available upon reasonable request, approved by the Ethics Committee of Peking Union Medical College Hospital, and the authors declare no conflicts of interest, confirming the work is original and has not been submitted or published elsewhere.
Similar articles
-
Growth plate continuity on knee MRI predicts growth hormone effect in mid-to-late puberty with idiopathic short stature.Endocrine. 2025 Aug 27. doi: 10.1007/s12020-025-04349-x. Online ahead of print. Endocrine. 2025. PMID: 40864383
-
A Growth Prediction Model from Mid-Puberty to Near Adult Height in Adolescents with Idiopathic Isolated Growth Hormone Deficiency Treated with Growth Hormone.Horm Res Paediatr. 2025 Jul 18:1-12. doi: 10.1159/000547488. Online ahead of print. Horm Res Paediatr. 2025. PMID: 40684769
-
Recombinant growth hormone for idiopathic short stature in children and adolescents.Cochrane Database Syst Rev. 2003;(4):CD004440. doi: 10.1002/14651858.CD004440. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004440. doi: 10.1002/14651858.CD004440.pub2. PMID: 14584015 Updated.
-
Efficacy, safety, and outcomes of growth hormone treatment in children with idiopathic short stature.Growth Horm IGF Res. 2025 Aug 9;82:101661. doi: 10.1016/j.ghir.2025.101661. Online ahead of print. Growth Horm IGF Res. 2025. PMID: 40848513 Review.
-
Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.J Clin Endocrinol Metab. 2009 Oct;94(10):3721-30. doi: 10.1210/jc.2009-0425. Epub 2009 Jul 7. J Clin Endocrinol Metab. 2009. PMID: 19584188
References
-
- S. Pedicelli, E. Peschiaroli, E. Violi, S. Cianfarani, Controversies in the definition and treatment of idiopathic short stature (ISS). J. Clin. Res. Pediatr. Endocrinol. 1(3), 105–115 (2009). https://doi.org/10.4008/jcrpe.v1i3.53 - DOI - PubMed - PMC
-
- W. Zegarra, S. Ranadive, D. Toulan, E.K. Neely, Anastrozole vs letrozole to augment height in pubertal males with idiopathic short stature: A 3-Year randomized trial. J. Endocr. Soc. 8(10), bvae141 (2024). https://doi.org/10.1210/jendso/bvae141 - DOI - PubMed - PMC
-
- A. Deodati, S. Cianfarani, Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ. 342, c7157 (2011). https://doi.org/10.1136/bmj.c7157 - DOI - PubMed
-
- L. Torres-Santiago, N. Mauras, Approach to the peripubertal patient with short stature. J. Clin. Endocrinol. Metab. 109(7), e1522–e1533 (2024). https://doi.org/10.1210/clinem/dgae011 - DOI - PubMed
-
- M. Yackobovitch-Gavan, A. Tenenbaum, M. Phillip, L. Lazar, T. Oron, Aromatase-inhibitors treatment alone or with GH increases final height in Short-Statured pubertal Boys - Real-World data. J Clin. Endocrinol. Metab Published Online April. 7, dgaf224 (2025). https://doi.org/10.1210/clinem/dgaf224 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources